Relationship between gene expression profile class and tumor thickness regression after plaque brachytherapy for choroidal melanoma

Abstract Background and objective To examine the relationship between gene expression profile class and tumor thickness reduction as measured by ultrasonography in response to plaque brachytherapy using a single-center, retrospective cohort study. Methods A total of 15 patients with choroidal melano...

Full description

Bibliographic Details
Main Authors: Arjun Sharma, John E. Mignano, Jay S. Duker
Format: Article
Language:English
Published: BMC 2022-07-01
Series:International Journal of Retina and Vitreous
Subjects:
Online Access:https://doi.org/10.1186/s40942-022-00397-x
_version_ 1811293468809494528
author Arjun Sharma
John E. Mignano
Jay S. Duker
author_facet Arjun Sharma
John E. Mignano
Jay S. Duker
author_sort Arjun Sharma
collection DOAJ
description Abstract Background and objective To examine the relationship between gene expression profile class and tumor thickness reduction as measured by ultrasonography in response to plaque brachytherapy using a single-center, retrospective cohort study. Methods A total of 15 patients with choroidal melanoma who underwent biopsy for gene expression profiling and were treated with plaque brachytherapy from a single institution from 12/8/14 through 12/19/19 were retrospectively reviewed for clinical characteristics and rate of tumor regression. Ultrasonographic B-scan tumor height was recorded just prior to plaque placement and following plaque removal in the patient’s chart to assess percent reduction in tumor thickness from baseline. Results A total of 15 patients met inclusion criteria and were analyzed in this study. Minimum follow-up was 6 months after plaque removal. The percent regression in tumor thickness from baseline as measured by ultrasonography was greater for class 2 tumors than for class 1 tumors at 12-month follow up after treatment, and this difference was statistically significant (P = 0.012). There was no statistical significance in reduction at 3 months (P = 0.46) and 9 months (P = 0.10) after plaque brachytherapy. Although not statistically significant, class 2 tumors appeared to regress more rapidly than class 1 tumors in response to radiation. Conclusions In this study, class 2 choroidal melanoma tumors show a more rapid anatomic response to treatment than class 1 tumors at 12 months post plaque brachytherapy.
first_indexed 2024-04-13T05:01:53Z
format Article
id doaj.art-9149a5c90d2d480594b97cd752ade583
institution Directory Open Access Journal
issn 2056-9920
language English
last_indexed 2024-04-13T05:01:53Z
publishDate 2022-07-01
publisher BMC
record_format Article
series International Journal of Retina and Vitreous
spelling doaj.art-9149a5c90d2d480594b97cd752ade5832022-12-22T03:01:19ZengBMCInternational Journal of Retina and Vitreous2056-99202022-07-01811410.1186/s40942-022-00397-xRelationship between gene expression profile class and tumor thickness regression after plaque brachytherapy for choroidal melanomaArjun Sharma0John E. Mignano1Jay S. Duker2Tufts University School of MedicineDepartment of Radiation Oncology, Tufts Medical CenterTufts University School of MedicineAbstract Background and objective To examine the relationship between gene expression profile class and tumor thickness reduction as measured by ultrasonography in response to plaque brachytherapy using a single-center, retrospective cohort study. Methods A total of 15 patients with choroidal melanoma who underwent biopsy for gene expression profiling and were treated with plaque brachytherapy from a single institution from 12/8/14 through 12/19/19 were retrospectively reviewed for clinical characteristics and rate of tumor regression. Ultrasonographic B-scan tumor height was recorded just prior to plaque placement and following plaque removal in the patient’s chart to assess percent reduction in tumor thickness from baseline. Results A total of 15 patients met inclusion criteria and were analyzed in this study. Minimum follow-up was 6 months after plaque removal. The percent regression in tumor thickness from baseline as measured by ultrasonography was greater for class 2 tumors than for class 1 tumors at 12-month follow up after treatment, and this difference was statistically significant (P = 0.012). There was no statistical significance in reduction at 3 months (P = 0.46) and 9 months (P = 0.10) after plaque brachytherapy. Although not statistically significant, class 2 tumors appeared to regress more rapidly than class 1 tumors in response to radiation. Conclusions In this study, class 2 choroidal melanoma tumors show a more rapid anatomic response to treatment than class 1 tumors at 12 months post plaque brachytherapy.https://doi.org/10.1186/s40942-022-00397-xChoroidMelanomaGEP testingPlaque brachytherapy
spellingShingle Arjun Sharma
John E. Mignano
Jay S. Duker
Relationship between gene expression profile class and tumor thickness regression after plaque brachytherapy for choroidal melanoma
International Journal of Retina and Vitreous
Choroid
Melanoma
GEP testing
Plaque brachytherapy
title Relationship between gene expression profile class and tumor thickness regression after plaque brachytherapy for choroidal melanoma
title_full Relationship between gene expression profile class and tumor thickness regression after plaque brachytherapy for choroidal melanoma
title_fullStr Relationship between gene expression profile class and tumor thickness regression after plaque brachytherapy for choroidal melanoma
title_full_unstemmed Relationship between gene expression profile class and tumor thickness regression after plaque brachytherapy for choroidal melanoma
title_short Relationship between gene expression profile class and tumor thickness regression after plaque brachytherapy for choroidal melanoma
title_sort relationship between gene expression profile class and tumor thickness regression after plaque brachytherapy for choroidal melanoma
topic Choroid
Melanoma
GEP testing
Plaque brachytherapy
url https://doi.org/10.1186/s40942-022-00397-x
work_keys_str_mv AT arjunsharma relationshipbetweengeneexpressionprofileclassandtumorthicknessregressionafterplaquebrachytherapyforchoroidalmelanoma
AT johnemignano relationshipbetweengeneexpressionprofileclassandtumorthicknessregressionafterplaquebrachytherapyforchoroidalmelanoma
AT jaysduker relationshipbetweengeneexpressionprofileclassandtumorthicknessregressionafterplaquebrachytherapyforchoroidalmelanoma